The outage that hit Amazon Web Services and took out vital services worldwide was the result of a single failure that ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis ...

Shadow AI DetectionShadow AI often hides in day-to-day tools; chatbots, plug-ins, or automation apps.It rarely looks like a threat; it starts as convenience.The signs: odd data access, unknown app ...

Sagimet Biosciences shares rose after the company's acne treatment met all primary and secondary endpoints in a phase 3 trial. The stock gained 17% to $8.55 Friday. Shares are up 87% this year.

"Entera’s oral osteoporosis drug meets endpoints in Phase II trial" was originally created and published by Clinical Trials ...

On Monday one of Amazon Web Services (AWS) data centre, located in the east coast of the U.S., began experiencing “increased ...

Berry Consultants, LLC announced the release of FACTS 8, the latest version of its industry-leading Fixed and Adaptive Clinical Trial Simulator (FACTS).

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

Progressive maritime organizations are moving beyond traditional, IT-centric security approaches to adopt models tailored for ...

Relay Therapeutics, Inc. leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety & efficacy. Learn more ...

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free ...

The trial was conducted by  Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...